CAPRICOR THERAPEUTICS, INC. Balance Sheet
CAPR / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
CAPRICOR THERAPEUTICS, INC. had $356M in total assets and $306M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $287.8M | $11.3M | $14.7M | $9.6M | $34.9M | $32.7M | $3.9M | $4.3M | $6.1M | $3.2M | $5.6M | $8.0M | $1.7M | $170.1K | $1.6M |
| Current Assets | $322.9M | $163.4M | $50.9M | $42.9M | $36.4M | $33.7M | $10.5M | $8.5M | $15.7M | $18.1M | $14.0M | $11.6M | $3.7M | $5.2M | $1.3M |
| PP&E (Net) | $18.3M | $5.6M | $5.6M | $4.6M | $1.8M | $850.8K | $442.8K | $574.2K | $372.1K | $435.3K | $318.6K | $229.5K | $74.2K | $33.9K | $9.7K |
| Goodwill | - | - | - | - | - | - | - | - | - | - | - | - | $1.9M | - | - |
| Total Assets | $355.9M | $170.5M | $58.7M | $50.1M | $41.3M | $34.6M | $11.1M | $9.2M | $16.3M | $18.7M | $16.1M | $13.6M | $5.5M | $5.4M | $1.4M |
| Current Liabilities | $35.8M | $21.0M | $31.3M | $23.6M | $4.1M | $3.0M | $898.0K | $1.3M | $1.7M | $4.9M | $6.5M | $6.3M | $2.1M | $529.2K | $541.4K |
| Shareholders' Equity | $305.8M | $145.5M | $22.6M | $11.8M | $31.4M | $28.2M | $4.6M | $4.6M | $11.2M | -$4.0M | -$1.0M | -$6.2M | -$534.9K | $4.9M | $1.7M |